NTF3
Basic information
Region (hg38): 12:5432108-5521536
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 4 |
Variants in NTF3
This is a list of pathogenic ClinVar variants found in the NTF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-5494276-T-C | not specified | Uncertain significance (Jan 12, 2024) | ||
12-5494366-A-C | not specified | Uncertain significance (Apr 04, 2024) | ||
12-5494407-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
12-5494423-G-A | not specified | Uncertain significance (May 31, 2022) | ||
12-5494432-A-T | not specified | Uncertain significance (Feb 12, 2024) | ||
12-5494440-G-A | Hirschsprung disease, susceptibility to, 1 | Uncertain significance (Apr 01, 2015) | ||
12-5494441-G-A | Aganglionic megacolon | Benign (-) | ||
12-5494476-A-G | not specified | Uncertain significance (Dec 02, 2021) | ||
12-5494484-C-T | Benign (Sep 14, 2018) | |||
12-5494540-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
12-5494564-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
12-5494572-A-C | not specified | Uncertain significance (Aug 11, 2021) | ||
12-5494620-C-G | not specified | Uncertain significance (Jan 10, 2023) | ||
12-5494621-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
12-5494651-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
12-5494760-C-T | Benign (May 24, 2018) | |||
12-5494803-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
12-5494815-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
12-5494823-C-T | Benign (Aug 20, 2018) | |||
12-5494832-G-A | Likely benign (Jul 01, 2022) | |||
12-5494901-A-G | Benign (Jul 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTF3 | protein_coding | protein_coding | ENST00000423158 | 2 | 89425 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.932 | 0.0679 | 125744 | 0 | 3 | 125747 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.74 | 108 | 172 | 0.628 | 0.0000123 | 1736 |
Missense in Polyphen | 40 | 86.146 | 0.46433 | 829 | ||
Synonymous | 0.423 | 69 | 73.6 | 0.937 | 0.00000554 | 540 |
Loss of Function | 3.08 | 1 | 13.0 | 0.0771 | 9.99e-7 | 114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000621 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to promote the survival of visceral and proprioceptive sensory neurons.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;MAPK Signaling Pathway;PI3K-Akt Signaling Pathway;Signal Transduction;role of erk5 in neuronal survival pathway;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;NTF3 activates NTRK2 (TRKB) signaling;Signaling by NTRK2 (TRKB);Signaling by NTRKs;BDNF;SHP2 signaling;GPCR signaling-G alpha i;Signaling by Receptor Tyrosine Kinases;Neurotrophic factor-mediated Trk receptor signaling;p75(NTR)-mediated signaling;Trk receptor signaling mediated by the MAPK pathway
(Consensus)
Recessive Scores
- pRec
- 0.530
Intolerance Scores
- loftool
- 0.448
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.352
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.619
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntf3
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype;
Gene ontology
- Biological process
- activation of MAPK activity;positive regulation of receptor internalization;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling;nervous system development;peripheral nervous system development;memory;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of phospholipase C activity;positive regulation of phosphatidylinositol 3-kinase signaling;nerve development;positive regulation of cell migration;activation of protein kinase B activity;positive regulation of peptidyl-serine phosphorylation;nerve growth factor signaling pathway;regulation of apoptotic process;negative regulation of neuron apoptotic process;regulation of neuron differentiation;neuron projection morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;modulation of chemical synaptic transmission;positive chemotaxis;induction of positive chemotaxis;activation of GTPase activity;positive regulation of actin cytoskeleton reorganization
- Cellular component
- extracellular region;extracellular space;synaptic vesicle;axon;dendrite;cytoplasmic vesicle
- Molecular function
- signaling receptor binding;neurotrophin receptor binding;protein binding;growth factor activity;chemoattractant activity